Related by context. All words. (Click for frequent words.) 78 BRCA mutation 76 BRCA2 mutations 75 BRCA1 mutations 74 BRCA2 mutation 71 endometrial cancers 70 BRCA1 70 BRCA1 mutation 69 colorectal neoplasia 69 BRCA 69 BRCA gene mutations 69 BRCA2 mutation carriers 69 hereditary breast cancer 67 BRCA2 gene mutation 67 atypical hyperplasia 67 subclinical hyperthyroidism 67 BRCA carriers 67 contralateral breast cancer 67 colorectal cancer CRC 66 BRCA gene mutation 66 BRCA mutation carriers 66 BRCA1 mutation carriers 66 breast cancer gene mutation 66 chlamydial infection 66 BRCA1 gene 66 oophorectomy 65 atypia 65 TGFBR1 * 6A 65 BRCA2 carriers 65 prostate cancer CaP 65 LQTS 65 EGFR mutation 65 adenomatous polyps 65 advanced neoplasia 65 KRAS mutations 65 breast cancers 65 prophylactic mastectomy 64 nonmelanoma skin cancers 64 advanced adenomas 64 gene mutations 64 estrogen receptor negative 64 noncarriers 64 BRCA2 gene 64 mutated BRCA1 64 ApoE4 gene 64 BRCA genes 64 BRCA2 63 epithelial ovarian cancer 63 nonmelanoma skin cancer 63 Ashkenazi Jewish 63 colorectal cancer 63 PCa 63 prostate cancers 63 thrombophilia 63 abnormal mammograms 63 oropharyngeal cancer 63 invasive cervical cancer 63 lobular breast cancer 63 atypical ductal hyperplasia 63 distant metastases 63 pCR 62 axillary node dissection 62 PSA velocity 62 preventive mastectomies 62 ASCUS 62 recurrent VTE 62 testicular germ cell 62 operable breast cancer 62 familial pancreatic cancer 62 HNSCC 62 poor metabolizers 62 lobular cancer 62 advanced adenoma 62 TT genotype 62 HNPCC 62 MetS 62 BRCA2 gene mutations 62 ductal breast cancer 62 extracolonic findings 62 breast cancer gene mutations 62 bladder cancers 62 GISTs 62 BRCA gene 62 invasive breast cancer 62 ovarian cancers 62 APOE e4 62 colorectal polyps 62 micrometastases 62 HER2 positive cancers 61 APOE ε4 61 CIN3 61 SLNB 61 KRAS mutation 61 NNRTI resistance 61 adenoma 61 postmenopausal breast cancer 61 pancreatic adenocarcinoma 61 colorectal neoplasms 61 genes BRCA1 61 invasive carcinoma 61 mutation 61 MGUS 61 contralateral breast 61 serous ovarian cancer 61 genetic variant 61 uterine cancers 61 elevated CRP 61 ApoE4 61 breast carcinoma 61 colorectal cancers 61 cervical lesions 61 lung adenocarcinoma 61 abnormal mammogram 61 chromosomal abnormalities 61 gallstone disease 61 endometrial carcinoma 61 polycystic ovary syndrome PCOS 61 EGFR mutations 61 tumor recurrence 61 gene variant 60 deCODE BreastCancer TM 60 colorectal cancer incidence 60 faulty BRCA2 gene 60 APOE4 60 abnormal Pap test 60 carotid stenosis 60 lobular carcinoma 60 gestational diabetes mellitus 60 penetrance 60 thyroid nodules 60 axillary dissection 60 antigen PSA 60 poorer prognosis 60 BRAF mutation 60 breast cancer genes BRCA1 60 PSA screening 60 premenopausal 60 subclinical hypothyroidism 60 nodal metastases 60 mtDNA mutations 60 gene variants 60 ε4 60 basal cell nevus syndrome 60 axillary lymph nodes 60 invasive ductal 60 salpingo oophorectomy 60 ovarian cancer 60 bowel cancers 60 malignancies 60 ovarian tumors 60 coronary calcification 60 Adjuvant chemotherapy 60 HER2 positive tumors 60 premenopausal breast cancer 60 bilateral oophorectomy 60 prostate specific 60 undergoing radical prostatectomy 60 CC genotype 60 pre cancerous polyps 60 pre menopausal 60 IgA deficiency 60 malignant lesions 59 sCJD 59 prophylactic mastectomies 59 adenocarcinomas 59 specific antigen 59 colorectal adenomas 59 deleterious mutation 59 MYH9 gene 59 elevated triglyceride levels 59 neoplasia 59 cancers 59 CIN2 + 59 diffuse gastric 59 NAFLD 59 germline mutations 59 peritoneal cancer 59 benign breast 59 latent TB infection 59 ductal cancer 59 APOE gene 59 curable cancers 59 prostate biopsy 59 HBV infection 59 gastric cancers 59 prostate pancreatic 59 GnRH agonists 59 latent TB 59 microdeletions 59 tumor subtypes 59 genetic mutations 59 CMV infection 59 CHD mortality 59 renal cell carcinomas 59 spontaneous preterm delivery 59 lipid abnormalities 59 #.#ng/ml 59 ADPKD 59 metastases 59 cerebral microbleeds 59 malignancy 59 p# mutation 59 estrogen receptor ER 59 EUS FNA 59 telomere lengths 59 APOE allele 59 colorectal tumors 59 preventive mastectomy 59 chromosomal disorders 59 placental malaria 59 BRCA1 gene mutation 59 adenomas 59 sporadic ALS 59 rs# [002] 59 T1DM 59 HPV infection 59 BARD1 59 CYP#C# [001] 59 abnormal cytology 59 aneuploidy 59 CYP#D# gene 59 mammographic density 59 biochemical recurrence 59 VUR 58 genetic variants 58 TCF#L# gene 58 PTEN mutations 58 genetic polymorphisms 58 p# mutations 58 Fragile X gene 58 genetic variants associated 58 TACI mutations 58 prenatal diagnosis 58 allele frequencies 58 FGFR2 58 endometrial cancer 58 node metastases 58 N. gonorrhoeae 58 chlamydia infection 58 metastatic cancer 58 breast cancer susceptibility genes 58 adjuvant radiation 58 abnormal Pap smears 58 lobular involution 58 benign lesions 58 APOE e4 gene 58 TP# mutation 58 genetic abnormalities 58 anovulatory infertility 58 rectal cancers 58 leiomyomas 58 BRAC2 58 CaP 58 HbF 58 unexplained infertility 58 clinically localized prostate 58 Hurthle cell 58 microalbuminuria 58 breast lesions 58 sentinel nodes 58 androgen deprivation 58 prostate adenocarcinoma 58 HER2 expression 58 hydroxyvitamin D levels 58 seminoma 58 differentiated thyroid 58 varicocele 58 breast tumors 58 gene variation 58 sentinel node biopsy 58 CYP#D# 58 screening colonoscopy 58 nonpregnant women 58 hormone therapy estrogen 58 hereditary predisposition 58 G#S mutation 58 hereditary hemochromatosis 58 narcolepsy cataplexy 58 inherited mutations 58 HER2 negative 58 estrogen progestin therapy 58 abnormal Pap 58 KIF6 carriers 58 microsatellite instability 58 cTnT 58 gene mutation 58 heterozygous 58 vertebral fracture 58 de ath 58 APOL1 58 neuroblastomas 58 squamous cell carcinomas 58 immunocompetent 58 denser breasts 58 precursor lesions 58 MSH2 58 MYCN amplification 58 Testicular cancer 58 CDH1 58 thyrotropin levels 58 invasive lobular 58 urine cytology 58 polycystic ovary syndrome 58 breast cancer subtypes 58 esophageal adenocarcinoma 58 recurrent ovarian cancer 58 spontaneous preterm birth 58 testicular cancers 58 mutations 58 HPV# 58 PTPN# 58 heterozygotes 58 K ras mutations 58 venous thrombosis 58 hormone receptor negative 58 ABCB1 58 homozygotes 57 familial ALS 57 situ LCIS 57 carotid plaques 57 breast cancer 57 slow metabolizers 57 Recurrence Score 57 testosterone supplementation 57 basal cell carcinomas 57 renal tumors 57 HPV infections 57 KIF6 gene 57 estrogen receptor positive 57 breast carcinomas 57 ovarian carcinoma 57 lobular carcinomas 57 dysglycemia 57 lymph node metastases 57 precancer 57 CIN3 + 57 lymph node removal 57 chromosomal aberrations 57 genotype 57 breast endometrial 57 standard chemotherapy regimens 57 premalignant lesions 57 benign proliferative breast 57 somatic mutations 57 metastatic disease 57 invasive lobular carcinoma 57 coinfection 57 breast cancer recurrence 57 coronary artery calcium 57 CHEK2 57 AAT deficiency 57 CMV disease 57 HGPIN 57 seronegative 57 anal cancers 57 subclinical atherosclerosis 57 gastric cancer 57 prediabetes 57 pleural mesothelioma 57 lymph node involvement 57 HCV infection 57 Rectal cancer 57 colorectal adenoma 57 alleles 57 mesotheliomas 57 mutated gene 57 grade gliomas 57 androgen deficiency 57 Thyroid nodules 57 colon tumors 57 T2DM 57 cardioembolic stroke 57 HER2 overexpression 57 recurrent miscarriage 57 KRAS wild 57 bowel polyps 57 sentinel lymph node biopsy 57 proband 57 recurrent miscarriages 57 ApoE4 allele 57 osteoporotic fracture 57 serum PSA 57 tamoxifen therapy 57 GBV C 57 BRAF mutations 57 tuberculin skin testing 57 tanned indoors 57 abnormal glucose tolerance 57 GBA mutations 57 nonfasting triglyceride levels 57 CCR5 delta# 57 chronic prostatitis 57 postoperative delirium 57 PSADT 57 untreated celiac disease 57 LTBI 57 gene BRCA2 57 asymptomatic carotid stenosis 57 serum selenium 57 HBsAg 57 FGFR2 gene 57 virologic failure 57 metastatic RCC 57 axillary node 57 microscopic hematuria 57 dose ionizing radiation 56 neoplasia PIN 56 BCG vaccinated 56 folate deficiency 56 liver transplant recipients 56 atherothrombotic disease 56 cryptorchidism 56 postmenopausal hormone 56 gynecologic malignancy 56 microscopic colitis 56 MTHFR 56 liver metastasis 56 radical nephrectomy 56 preoperative chemotherapy 56 pancreatic cancers 56 clinically insignificant 56 cranial irradiation 56 transferrin saturation 56 oesophageal adenocarcinoma 56 univariate analyzes 56 HPV genotypes 56 rs# [001] 56 Anal cancer 56 colon cancers 56 Uterine cancer 56 psychiatric comorbidities 56 locoregional recurrence 56 #q# deletion 56 Radical prostatectomy 56 mutated K ras 56 varicoceles 56 Heavy menstrual bleeding 56 premenopausal women 56 coronary disease 56 breast biopsies 56 colonic polyps 56 APOE genotype 56 intravenous bisphosphonates 56 Cholangiocarcinoma 56 hormone receptor positive 56 endometrial hyperplasia 56 colon polyps 56 NF1 56 preterm delivery 56 CYP#D# genotype 56 VKORC1 56 Recurrences 56 endocrine therapies 56 locoregional 56 prostate cancer PCa 56 folate intake 56 skeletal metastases 56 hepatocellular carcinomas 56 systemic lupus erythematosus SLE 56 carotid IMT 56 venous thromboembolism 56 prophylactic oophorectomy 56 familial hypercholesterolemia 56 urinary symptoms 56 leukaemias 56 obstructive coronary artery 56 familial clustering 56 apolipoprotein E gene 56 HER2 positive breast cancer 56 Colon polyps 56 GIST tumors 56 Flexi Scope 56 prostate biopsies 56 malignant lymphoma 56 taxane therapy 56 colorectal polyp 56 nodal metastasis 56 cardiovascular mortality 56 CIN2 56 NP CRNs 56 neoplasias 56 adenocarcinoma 56 lung tumors 56 chronic HBV 56 genetic mutation 56 neuroblastoma tumors 56 hamartomas 56 undergone hysterectomy 56 metastatic lesions 56 MC1R gene 56 CVD mortality 56 folate supplementation 56 carcinomas 56 GBM tumors 56 metastatic prostate cancer 56 AVODART 56 axillary lymph node dissection 56 cervical abnormalities 56 platelet reactivity 56 genomewide 56 adjuvant therapies 56 selenium supplementation 56 epithelial tumors 56 inherited predisposition 56 kidney transplant recipients 56 basal cell carcinoma BCC 56 TP# mutations 56 EBRT 56 core needle biopsy 56 HER2 gene 56 recurrent UTI 56 herpes infection 56 coinfected 56 seropositivity 56 white matter hyperintensities 56 sentinel node 56 tumors 56 malignant polyps 56 autoantibodies 56 elevated LDL cholesterol 56 lipid lowering drugs 56 osteoporotic fractures 56 faulty BRCA genes 56 postoperative mortality 56 primary ovarian insufficiency 56 carotid plaque 56 chromosomal rearrangement 56 familial predisposition 56 testicular tumors 56 Cristofanilli 56 grade cervical intraepithelial 56 intestinal metaplasia 56 exemestane 56 G allele 56 latent tuberculosis infection 56 dysplastic nevi 56 prostate carcinoma 56 HBeAg negative 56 Amniocentesis 56 Barrett esophagus 56 Chlamydia infection 56 familial adenomatous polyposis 55 HCV infected 55 nonischemic 55 Chlamydia trachomatis 55 Klinefelter syndrome 55 Li Fraumeni 55 abnormal Pap smear 55 SE alleles 55 malignant nodules 55 nonalcoholic steatohepatitis NASH 55 hepatitis C genotype 55 microvascular disease 55 bacterial vaginosis 55 lipid lowering medications 55 uveal melanoma 55 Subgroup analyzes 55 late onset hypogonadism 55 mCRC patients 55 colorectal liver metastases 55 ALND 55 perioperative morbidity 55 asymptomatic 55 metastatic prostate 55 invasive ductal carcinoma 55 squamous cell lung cancer 55 Epidemiologic studies 55 genetic syndromes 55 probands 55 cervical intraepithelial neoplasia 55 undetectable PSA 55 malignant pleural mesothelioma 55 relapsed ovarian cancer 55 NMIBC 55 neoplasms 55 Thyroid cancer 55 symptomatic fibroids 55 TCF#L# 55 rectal cancer 55 atypical fractures 55 FTO variant 55 radical prostatectomy RP 55 hematuria 55 dizygotic twins 55 KIF6 gene variant 55 pelvic lymphadenectomy 55 troponin T 55 thyroid hormone levels 55 susceptibility gene 55 Prostatitis 55 aneuploidy screening 55 prognostic factors 55 T2D 55 missense mutations 55 prostate cancer 55 Uterine fibroids 55 diagnosed prenatally 55 prenatally diagnosed 55 asymptomatic hypothyroidism 55 preterm deliveries 55 HIV HCV coinfected 55 gestational diabetes 55 prognostic markers 55 tibolone 55 acute myelogenous leukemia AML 55 mammary cancers 55 sigmoidoscopy 55 USPSTF recommends 55 β blockers 55 BRCA1 BRCA2 55 chronic HBV infection 55 precancerous cervical lesions 55 UGT#A# * 55 neoadjuvant therapy 55 serum creatinine levels 55 PSA prostate 55 perioperative mortality 55 XMRV infection 55 H. pylori infection 55 nondiabetic 55 K#N 55 shorter telomeres 55 biopsies 55 albuminuria 55 adjuvant radiotherapy 55 surgical biopsy 55 C#Y 55 KRAS status 55 Hepatitis B virus 55 definite stent thrombosis 55 ALCL 55 ICD implantation 55 lymph node dissection 55 Haptoglobin 55 metastatic tumors 55 situ DCIS 55 digital rectal examination 55 catheter angiography 55 BMPR2 55 Ashkenazi Jews 55 cutaneous melanoma 55 Colorectal cancer screening 55 proliferative diabetic retinopathy 55 Prehypertension 55 subgroup analyzes 55 genetic variations 55 CYP#C# * 55 distal colon cancer 55 retrospective cohort 55 thyroid cancers 55 localized prostate cancer 55 K#R [002] 55 TEAEs 55 surgical biopsies 55 cosmetic breast implants 55 polyp recurrence 55 coinfected patients 55 metastatic kidney 55 thrombotic events 55 chorioamnionitis 55 thyroid dysfunction 55 invasive prenatal 55 apolipoprotein E4 55 distant metastasis 55 mutant allele 55 cTnT levels 55 peritoneal carcinomatosis 55 ovulation induction 55 BRCA2 genes 55 precancerous polyp 55 relapsed SCLC 55 G6PD deficiency 55 pharyngeal cancer 55 gynecologic cancers 55 hormonal therapies 55 fecal occult blood 55 lipid lowering therapy 55 karyotype 55 intestinal polyps 55 lymph node biopsies 55 chlamydia infections 55 breast cancer recurrences 55 allele 55 anti JCV antibodies 55 cervical carcinoma 55 multivariate analyzes 55 spontaneous mutations 55 tumor histology 55 thyroglobulin 55 trisomy 55 atrophic gastritis 55 MHC genes 55 molecular subtypes 55 BRCA testing 55 homozygosity 55 antihypertensive medication 55 2 diabetes T2D 55 multiple gestations 55 confidence interval #.#-#.# 55 EGFR gene 55 ICDs implanted 55 urothelial carcinoma 55 coronary calcium 55 histological subtype 55 squamous cell cancers 55 normal karyotype 55 premature ovarian 55 IKZF1 55 precancerous cervical 55 premature menopause 55 myeloproliferative neoplasms 55 venous blood clots 55 hormonal therapy 55 dentinal hypersensitivity 55 papillary thyroid cancer 55 V Leiden 55 castrate resistant prostate cancer 55 neoplasm 54 EpCAM expression 54 hematopoietic cancers 54 lignan intake 54 irregular menstrual cycles 54 malignant neoplasm 54 undergone radical prostatectomy 54 Asymptomatic 54 HLA genes 54 NAT2 54 colorectal carcinomas 54 invasive coronary angiography 54 antihypertensive therapy 54 incidentalomas 54 gastric adenocarcinoma 54 statin medications 54 Prostate Specific Antigen PSA 54 SHBG 54 olaparib 54 nonseminoma 54 infantile hemangiomas 54 adjuvant therapy 54 uterine ovarian 54 flutamide 54 melanomas 54 haematopoietic 54 baseline mammogram 54 biochemical relapse 54 Bladder cancer 54 benign polyps 54 thiopurine 54 homozygous 54 neurodevelopmental impairment 54 comorbidities 54 undergo prostate biopsy 54 adiponectin levels 54 medullary thyroid cancer 54 extracolonic 54 chemopreventive agent 54 del 5q MDS 54 frequently benign tumor 54 mycophenolate mofetil 54 histologic subtype 54 SLN biopsy 54 haplotypes 54 genital HPV infections 54 candidemia 54 CETP VV 54 genetic abnormality 54 fibrocystic disease 54 microbleeds 54 impaired fasting glucose 54 postmenopausal hormones 54 variant allele 54 mammary tumors 54 cerebral infarction 54 disease NAFLD 54 HPV 54 hepatitis B infection 54 HbA1C 54 CNVs 54 hormone deprivation 54 esophageal squamous cell carcinoma 54 CYP#C# [002] 54 MTHFR gene 54 heavily pretreated 54 Helicobacter pylori infection 54 meningioma 54 diabetes mellitus DM 54 Hashimoto thyroiditis 54 H. pylori 54 Trichomonas vaginalis 54 Framingham Risk Score 54 FXTAS 54 precocious puberty 54 causal variants 54 MELD scores 54 de novo mutations 54 benign noncancerous 54 baseline HbA1c 54 esophageal cancers 54 recurrent tonsillitis 54 PTEN mutation 54 mosaicism 54 elevated LDH 54 carcinoid tumor 54 Squamous 54 Reynolds Risk Score 54 LV dysfunction 54 proteinuria 54 gastrointestinal cancers 54 recurrent stroke 54 Li Fraumeni syndrome 54 rs# [003] 54 SHBG levels 54 ADRB2 54 intensive statin therapy 54 thromboembolic events 54 rheumatoid factor 54 hyperemesis gravidarum 54 breast ovarian 54 precancers 54 prognostic indicator 54 nephron sparing surgery 54 progesterone receptor negative 54 molecular abnormalities 54 PALB2 54 herpesviruses 54 K ras 54 cytoreductive surgery 54 RBP4 54 perimenopausal women 54 carcinoid tumors 54 HCV infections 54 metastatic melanomas 54 tamoxifen 54 genital herpes infections 54 cognitively normal 54 Stomach cancer 54 Pancreatic neuroendocrine tumors 54 vasomotor symptoms 54 genotypic 54 postoperative morbidity 54 asymptomatic PAD 54 lung cancers 54 bronchopulmonary dysplasia BPD 54 cranial radiation 54 gonococcal infections 54 seminomas 54 aneuploidies 54 estrogen receptor 54 TOP2A 54 beta carotene supplementation 54 lymph node metastasis 54 epididymitis 54 cystectomy 54 statin therapy 54 thalassemia trait 54 NRTI resistance 54 colon rectal 54 RET PTC rearrangements 54 ovulatory cycles 54 polymorphisms 54 MLH1 54 invasive cervical cancers 54 fasting glucose levels 54 ErbB2 positive 54 female endoscopist 54 HCV antibody 54 PARP inhibition 54 soft tissue sarcomas 54 CDKN2A 54 perioperative complications 54 neoadjuvant chemotherapy 54 SNPs 54 ovarian malignancy 54 dizygotic 54 Wwox 54 heritable variation 54 chromosomal defects 54 mammographically 54 lymphomas 54 albumin excretion 54 preeclampsia 54 antenatal depression 54 invasive diagnostic 54 osteosarcomas 54 haemorrhagic stroke 54 periodontitis 54 endometrial thickness 54 parous women 54 H. pylori eradication 54 cytologic 54 atopy 54 coronary angiography 54 squamous cell skin 54 MMSE scores 54 oligodendrogliomas 54 oropharyngeal cancers 54 pathologic fractures 54 screening mammogram 54 variant alleles 54 dysfunctional voiding 54 S. aureus infections 54 imatinib Gleevec 54 nonsmall cell lung cancer 54 neoadjuvant 54 NPM1 mutations 54 cardiac troponin T 54 mutated BRAF gene 54 gestational hypertension 54 Acute myeloid leukemia 53 arterial thickening 53 Her2 53 ALK mutations 53 K ras gene 53 ovarian breast 53 serologic testing 53 serum calcium 53 HER2 positive 53 adrenal function 53 mammographic screening 53 nucleoside analogues 53 elevated depressive symptoms 53 premenstrual syndrome PMS 53 FMR1 gene 53 neurologic complications 53 pre cancerous lesions 53 carcinoid 53 HPV subtypes 53 HBV vaccination 53 GSTP1 53 rectal gonorrhea 53 genital ulcers 53 nonvertebral fractures 53 hepatocellular carcinoma HCC 53 knee OA 53 systemic scleroderma 53 supratentorial 53 warfarin dosing 53 microvascular complications 53 ovarian endometrial 53 TMPRSS2 ERG fusion 53 ovarian hyperstimulation 53 BRCA breast cancer 53 malignant transformation 53 precancerous tumors 53 adnexal mass 53 intestinal biopsy 53 IDH1 mutation 53 microdeletion 53 deleterious mutations 53 urolithiasis 53 HLA B 53 fetal chromosomal 53 familial aggregation 53 immunodeficient 53 cystatin C 53 ependymoma 53 fetuin 53 symptomatic BPH 53 gliomas 53 non squamous NSCLC 53 genotypic resistance 53 risk HPV genotypes 53 eribulin 53 carotid endarterectomy 53 oesophageal cancer 53 mucinous 53 HER2 amplification 53 Sjögren syndrome 53 vitamin D insufficiency 53 warfarin therapy 53 oral bisphosphonates 53 chemoradiation 53 digital rectal exams 53 NOMID 53 subfertility 53 subclinical 53 GSTT1 53 PSA nadir 53 LRP5 53 colorectal cancer screening 53 azoospermia 53 adjuvant chemotherapy 53 abnormal pap smears 53 promoter methylation 53 postmenopausal 53 dopamine receptor gene 53 ascertainment bias 53 anastrozole 53 cisplatin resistant 53 HER2 + 53 Endometrial cancer 53 DCIS 53 paroxysmal AF 53 virological response 53 thromboembolism 53 metastatic lung cancer 53 prostate cancer CRPC 53 lymphocytosis 53 Pap smear screening 53 arterial calcification